Vector |
Gene Therapy Clinical Trials |
Number |
% |
Adeno-associated virus |
238 |
8.1 |
Adenovirus |
541 |
18.5 |
Adenovirus + Maraba virus |
1 |
0 |
Adenovirus + Modified vaccinia Ankara virus (MVA) |
11 |
0.4 |
Adenovirus + Retrovirus |
3 |
0.1 |
Adenovirus + Sendai virus |
1 |
0 |
Adenovirus + Vaccinia virus |
8 |
0.3 |
Alphavirus (VEE) Replicon Vaccine |
1 |
0 |
Antisense oligonucleotide |
6 |
0.2 |
Bifidobacterium longum |
1 |
0 |
CRISPR-Cas9 |
12 |
0.4 |
E. coli |
2 |
0.1 |
Flavivirus |
8 |
0.3 |
Gene gun |
5 |
0.2 |
Herpes simplex virus |
99 |
3.4 |
Human Rhinovirus (RG-HRV16) |
1 |
0 |
Lactococcus lactis |
7 |
0.2 |
Lentivirus |
278 |
9.5 |
Lipofection |
119 |
4.1 |
Listeria monocytogenes |
31 |
1.1 |
Live Attenuated Salmonella |
1 |
0 |
Measles virus |
14 |
0.5 |
Modified Vaccinia Ankara virus (MVA) |
12 |
0.4 |
mRNA Electroporation |
6 |
0.2 |
Naked/Plasmid DNA |
452 |
15.4 |
Naked/Plasmid DNA + Adenovirus |
4 |
0.1 |
Naked/Plasmid DNA + Modified Vaccinia Ankara virus (MVA) |
2 |
0.1 |
Naked/Plasmid DNA + RNA transfer |
1 |
0 |
Naked/Plasmid DNA + Vaccinia virus |
3 |
0.1 |
Naked/Plasmid DNA + Vesicular stomatitis virus |
3 |
0.1 |
Newcastle disease virus |
1 |
0 |
Non-viral |
1 |
0 |
PiggyBacTM (PB) Transposon |
1 |
0 |
Poliovirus |
5 |
0.2 |
Poxvirus |
71 |
2.4 |
Poxvirus + Vaccinia virus |
40 |
1.4 |
Retrovirus |
514 |
17.5 |
Retrovirus + Lentivirus |
2 |
0.1 |
RNA transfer |
51 |
1.7 |
RNA transfer + Naked/Plasmid DNA |
1 |
0 |
RNA virus |
5 |
0.2 |
Saccharomyces cerevisiae |
9 |
0.3 |
Salmonella typhimurium |
4 |
0.1 |
Semliki forest virus |
2 |
0.1 |
Sendai virus |
4 |
0.1 |
Shigella dysenteriae |
1 |
0 |
Simian virus |
2 |
0.1 |
siRNA |
5 |
0.2 |
Sleeping Beauty transposon |
12 |
0.4 |
Streptococcus mutans |
1 |
0 |
Vaccinia virus |
133 |
4.5 |
Venezuelan equine encephalitis virus replicon |
3 |
0.1 |
Vesicular stomatitis virus |
6 |
0.2 |
Vibrio cholerae |
1 |
0 |
Unknown |
184 |
6.3 |
Total |
2930 |
|